These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 33485619)
1. Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis. Tsilimigras DI; Hyer JM; Diaz A; Moris D; Abbas A; Dillhoff M; Cloyd JM; Ejaz A; Beane JD; Tsung A; Pawlik TM Am J Surg; 2021 Sep; 222(3):570-576. PubMed ID: 33485619 [TBL] [Abstract][Full Text] [Related]
2. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer. Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013 [TBL] [Abstract][Full Text] [Related]
3. Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act. Kehl KL; Liao KP; Krause TM; Giordano SH J Clin Oncol; 2017 Feb; 35(6):645-651. PubMed ID: 28068172 [TBL] [Abstract][Full Text] [Related]
4. The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery. Mehta R; Ejaz A; Hyer JM; Tsilimigras DI; White S; Merath K; Sahara K; Bagante F; Paredes AZ; Cloyd JM; Dillhoff M; Tsung A; Pawlik TM Ann Surg Oncol; 2019 Nov; 26(12):4083-4090. PubMed ID: 31376033 [TBL] [Abstract][Full Text] [Related]
5. Relationship between cancer center accreditation and performance on publicly reported quality measures. Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202 [TBL] [Abstract][Full Text] [Related]
6. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison. Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos RC; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A AJR Am J Roentgenol; 2024 Aug; 223(2):e2431272. PubMed ID: 38899842 [No Abstract] [Full Text] [Related]
7. Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery. Mehta R; Tsilimigras DI; Paredes AZ; Sahara K; Dillhoff M; Cloyd JM; Ejaz A; White S; Pawlik TM Ann Surg Oncol; 2020 Jun; 27(6):1889-1897. PubMed ID: 32108924 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after resection of alcohol-related versus hepatitis-related hepatocellular carcinoma: A SEER-Medicare database analysis. Mehta R; Tang Qinghe ; Tsilimigras DI; Paredes A; Dillhoff M; Cloyd JM; Ejaz A; Tsung A; Spolverato G; Pawlik TM Am J Surg; 2021 Jul; 222(1):167-172. PubMed ID: 33131693 [TBL] [Abstract][Full Text] [Related]
9. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Birkmeyer NJ; Goodney PP; Stukel TA; Hillner BE; Birkmeyer JD Cancer; 2005 Feb; 103(3):435-41. PubMed ID: 15622523 [TBL] [Abstract][Full Text] [Related]
10. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence. In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278 [TBL] [Abstract][Full Text] [Related]
11. Hospital Accreditation Status and Treatment Differences Among Black Patients With Colon Cancer. Chan K; Palis BE; Cotler JH; Janczewski LM; Weigel RJ; Bentrem DJ; Ko CY JAMA Netw Open; 2024 Aug; 7(8):e2429563. PubMed ID: 39167405 [TBL] [Abstract][Full Text] [Related]
12. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615 [TBL] [Abstract][Full Text] [Related]
13. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery. Paulson EC; Mitra N; Sonnad S; Armstrong K; Wirtalla C; Kelz RR; Mahmoud NN Ann Surg; 2008 Oct; 248(4):675-86. PubMed ID: 18936581 [TBL] [Abstract][Full Text] [Related]
14. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131 [TBL] [Abstract][Full Text] [Related]
15. Survival outcomes of liver transplantation versus liver resection among patients with hepatocellular carcinoma: A SEER-based longitudinal study. Zhang K; Chen R; Gong X; Gao Y J Formos Med Assoc; 2019 Apr; 118(4):790-796. PubMed ID: 30482570 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database. Uhlig J; Sellers CM; Stein SM; Kim HS Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364 [TBL] [Abstract][Full Text] [Related]
17. The effect of national hospital accreditation in bariatric surgery on perioperative outcomes and long-term mortality. Telem DA; Talamini M; Altieri M; Yang J; Zhang Q; Pryor AD Surg Obes Relat Dis; 2015; 11(4):749-57. PubMed ID: 26001555 [TBL] [Abstract][Full Text] [Related]
18. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare. Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197 [TBL] [Abstract][Full Text] [Related]
19. Trends in Discharge Disposition Following Hepatectomy for Hepatocellular Carcinoma Among Medicare Beneficiaries. Dalmacy DM; Hyer JM; Diaz A; Paro A; Tsilimigras DI; Pawlik TM J Gastrointest Surg; 2021 Nov; 25(11):2842-2850. PubMed ID: 33821414 [TBL] [Abstract][Full Text] [Related]
20. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Zhang X; El-Serag HB; Thrift AP Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]